Benjamin Ware Starnes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin Ware Starnes has a total of 404 co-authors. Here are the top co-authors by number of shared publications:
Elina Quiroga
Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, WA
13 shared publicationsNiten Singh
11 shared publications- Nam T. Tran
Division of Vascular Surgery, Department of Surgery, Harborview Medical Center, University of Washington, Seattle, WA
10 shared publications Billi Tatum
Division of Vascular Surgery, University of Washington, Seattle, Wash
9 shared publications- Niten Singh
Department of Vascular and Endovascular Surgery, Madigan Army Medical Center, Tacoma, WA, Etats-Unis
7 shared publications Nam Tran
Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, WA
5 shared publications
Latest Publications
- 20 December 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (2) , 177-178
The New European Society for Vascular Surgery Clinical Practice Guidelines for Managing Vascular Trauma are Fresh, Bold, and Mostly Correct
- 20 December 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (2) , 177-178
The New European Society for Vascular Surgery Clinical Practice Guidelines for Managing Vascular Trauma are Fresh, Bold, and Mostly Correct
- Open Access
- 26 June 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 280 (4) , 633-639
Long-Term Results of Physician-Modified Endografts for the Treatment of Elective, Symptomatic, and Ruptured Juxtarenal Abdominal Aortic Aneurysms
Objective: The objective of this study was to report long term results of an ongoing physician-sponsored, investigational device exemption (IDE) pivotal clinical trial using physician-modified endovascular grafts (PMEGs) for the treatment of patients with juxtarenal aortic aneurysms. Methods: Data from a nonrandomized, prospective, consecutively enrolling IDE clinical trial were used. Data collection began on April 1, 2011, and data lock occurred on January 2, 2024, with outcomes analysis through December 31, 2023. Primary safety and effectiveness end points were used to measure treatment success. The safety end point was defined as the proportion of subjects who experienced a major adverse event within 30 days of the procedure. The effectiveness end point was the proportion of subjects who achieved treatment success. Treatment success required the following at 12 months: technical success, defined as successful delivery and deployment of a PMEG with preservation of intended branch vessels; and freedom from: type I and III endoleak, stent graft migration >10 mm, aortic aneurysm sack enlargement >5 mm, and aortic aneurysm rupture or open conversion. Results: Over the 12-year study period, 228 patients were enrolled; 205 began the implant procedure and 203 received PMEG. Thirteen patients withdrew prior to PMEG. Two withdrew (<1.0%) after failure to deploy due to tortuous iliac anatomy and are tracked as intent to treat and a total of 24 withdrew after receiving the PMEG implant. 44 patients died during the study period. A total of 14 were deemed lost to follow up. Fifty-nine completed the five-year follow-up period and 62 remain active in follow-up visits. Aneurysm anatomy, operative details, and lengths of stay were recorded and included: aneurysm diameter (mean, 67.5 mm; range, 49-124 mm), proximal seal zone length (mean, 41.6 mm; range, 18.9-92.9 mm), graft modification time (mean, 48.7 min), procedure time (mean, 137.7 min), fluoroscopy time (mean, 33.8 min), contrast material use (mean, 93.0 mL), estimated blood loss (mean, 118.8 mL), length of hospital stay (mean, 3.7 d) and ICU length of stay (mean, 1.6 d). A total of 575 fenestrations were created for 387 renal arteries, 181 superior mesenteric arteries (SMAs), and 7 celiac arteries. Renal arteries were in 96% of patients and included 410 renal artery stents in 203 patients. The SMA was stented as needed and included one patient with an SMA stent placed before the procedure, 19 during the procedure, and 2 patients underwent stent placement after the procedure. There were no open conversions or device migrations and one partial explant due to late distal graft occlusion. Three ruptures (1.4%) were recorded on days 830, 1346 and 1460. There was one presumed graft infection at 750 days (<0.5%) treated with? Thirty-day all-cause mortality was 2.9% (6/204). One type Ia, one type Ib, and seven type III endoleaks were identified during follow-up and treated with successful reintervention at the one year period. The overall rate of major adverse events at 30 days was 15% (29/194). Technical success was 93.7% and overall treatment success 82.6%. Conclusions: PMEG can be performed with low rates of long term morbidity and mortality, confirming our early and midterm reports that endovascular repair with PMEG is safe, durable and effective for managing patients with juxtarenal aortic aneurysms. While historically considered experimental, these results suggest that PMEG is a safe and durable option and should be considered for patients where off-the-shelf devices are not available.
- 26 June 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 280 (4) , 633-639
Open AccessLong-Term Results of Physician-Modified Endografts for the Treatment of Elective, Symptomatic, and Ruptured Juxtarenal Abdominal Aortic Aneurysms
Objective: The objective of this study was to report long term results of an ongoing physician-sponsored, investigational device exemption (IDE) pivotal clinical trial using physician-modified endovascular grafts (PMEGs) for the treatment of patients with juxtarenal aortic aneurysms. Methods: Data from a nonrandomized, prospective, consecutively enrolling IDE clinical trial were used. Data collection began on April 1, 2011, and data lock occurred on January 2, 2024, with outcomes analysis through December 31, 2023. Primary safety and effectiveness end points were used to measure treatment success. The safety end point was defined as the proportion of subjects who experienced a major adverse event within 30 days of the procedure. The effectiveness end point was the proportion of subjects who achieved treatment success. Treatment success required the following at 12 months: technical success, defined as successful delivery and deployment of a PMEG with preservation of intended branch vessels; and freedom from: type I and III endoleak, stent graft migration >10 mm, aortic aneurysm sack enlargement >5 mm, and aortic aneurysm rupture or open conversion. Results: Over the 12-year study period, 228 patients were enrolled; 205 began the implant procedure and 203 received PMEG. Thirteen patients withdrew prior to PMEG. Two withdrew (<1.0%) after failure to deploy due to tortuous iliac anatomy and are tracked as intent to treat and a total of 24 withdrew after receiving the PMEG implant. 44 patients died during the study period. A total of 14 were deemed lost to follow up. Fifty-nine completed the five-year follow-up period and 62 remain active in follow-up visits. Aneurysm anatomy, operative details, and lengths of stay were recorded and included: aneurysm diameter (mean, 67.5 mm; range, 49-124 mm), proximal seal zone length (mean, 41.6 mm; range, 18.9-92.9 mm), graft modification time (mean, 48.7 min), procedure time (mean, 137.7 min), fluoroscopy time (mean, 33.8 min), contrast material use (mean, 93.0 mL), estimated blood loss (mean, 118.8 mL), length of hospital stay (mean, 3.7 d) and ICU length of stay (mean, 1.6 d). A total of 575 fenestrations were created for 387 renal arteries, 181 superior mesenteric arteries (SMAs), and 7 celiac arteries. Renal arteries were in 96% of patients and included 410 renal artery stents in 203 patients. The SMA was stented as needed and included one patient with an SMA stent placed before the procedure, 19 during the procedure, and 2 patients underwent stent placement after the procedure. There were no open conversions or device migrations and one partial explant due to late distal graft occlusion. Three ruptures (1.4%) were recorded on days 830, 1346 and 1460. There was one presumed graft infection at 750 days (<0.5%) treated with? Thirty-day all-cause mortality was 2.9% (6/204). One type Ia, one type Ib, and seven type III endoleaks were identified during follow-up and treated with successful reintervention at the one year period. The overall rate of major adverse events at 30 days was 15% (29/194). Technical success was 93.7% and overall treatment success 82.6%. Conclusions: PMEG can be performed with low rates of long term morbidity and mortality, confirming our early and midterm reports that endovascular repair with PMEG is safe, durable and effective for managing patients with juxtarenal aortic aneurysms. While historically considered experimental, these results suggest that PMEG is a safe and durable option and should be considered for patients where off-the-shelf devices are not available.
- 25 April 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (3) , 678-684.e1
Early survival benefit of a low-profile endograft in blunt traumatic aortic injury
- 25 April 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 80 (3) , 678-684.e1
Early survival benefit of a low-profile endograft in blunt traumatic aortic injury
- 3 April 2024
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 105, 29-37
Complicated and Uncomplicated Isolated Abdominal Aortic Dissections Demonstrate Different Patient Characteristics and Outcomes
- 3 April 2024
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 105, 29-37
Complicated and Uncomplicated Isolated Abdominal Aortic Dissections Demonstrate Different Patient Characteristics and Outcomes
- 17 November 2023
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (3) , 562-568
Modified Harborview Risk Score improves ease in predicting mortality after ruptured abdominal aortic aneurysm repair
- 17 November 2023
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (3) , 562-568
Modified Harborview Risk Score improves ease in predicting mortality after ruptured abdominal aortic aneurysm repair
- Open Access
- 13 September 2023
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 9 (4) , 101320
Five-year outcome of a staged giant Shamblin type III carotid body tumor excision
- 13 September 2023
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 9 (4) , 101320
Open AccessFive-year outcome of a staged giant Shamblin type III carotid body tumor excision
- 1 November 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (5) , 1581-1587
Intraoperative consultation of vascular surgeons is increasing at a major American trauma center
- 1 November 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (5) , 1581-1587
Intraoperative consultation of vascular surgeons is increasing at a major American trauma center
- 1 November 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (5) , 1508-1518
Preoperative risk score accuracy confirmed in a modern ruptured abdominal aortic aneurysm experience
- 1 November 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (5) , 1508-1518
Preoperative risk score accuracy confirmed in a modern ruptured abdominal aortic aneurysm experience
- Open Access
- 1 June 2021
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 7 (2) , 197-202
Bilateral internal iliac branch device with ipsilateral deployment
- 1 June 2021
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 7 (2) , 197-202
Open AccessBilateral internal iliac branch device with ipsilateral deployment
- 1 April 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 73 (4) , 1117-1125
Zen and the art of bandsaw maintenance: An inquiry into values
- 1 April 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 73 (4) , 1117-1125
Zen and the art of bandsaw maintenance: An inquiry into values